Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Terumo Aims at Annual Sales of 1-2 Billion Yen for HeartSheet within 5-10 Years
Terumo Corporation expects to turn its regenerative medicine product HeartSheet into a product with annual sales of one to two billion yen within five to 10 years if it obtains additional indications and a more-efficient transplantation process is developed. Terumo…
To read the full story
Related Article
- Japan Grants 1st Conditional Approval to Terumo’s HeartSheet
September 24, 2015
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





